• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Could This Be Eli Lilly's Next Blockbuster Drug?

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Mar 20, 2022 at 11:02: PM
via
  • Mirikizumab could be used by tens of thousands of patients if approved by the U.S. Food and Drug Administration.
  • An ulcerative colitis indication could generate $800 million in annual sales for Eli Lilly in the U.S. alone.
  • Eli Lilly still looks like it could be a buy for growth investors.

article source
 




Top Bottom
Back
Quote